Terms: = Prostate cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
9 results:
1. Early Post-treatment prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced prostate cancer: An International Collaborative Analysis.
Rescigno P; Dolling D; Conteduca V; Rediti M; Bianchini D; Lolli C; Ong M; Li H; Omlin AG; Schmid S; Caffo O; Zivi A; Pezaro CJ; Morley C; Olmos D; Romero-Laorden N; Castro E; Saez MI; Mehra N; Smeenk S; Sideris S; Gil T; Banks P; Sandhu SK; Sternberg CN; De Giorgi U; De Bono JS
Eur Urol Oncol; 2020 Apr; 3(2):176-182. PubMed ID: 31307958
[TBL] [Abstract] [Full Text] [Related]
2. Negative Predictive Value of prostate Multiparametric Magnetic Resonance Imaging among Men with Negative prostate Biopsy and Elevated prostate Specific Antigen: A clinical outcome Retrospective Cohort Study.
Lo G; Burton KR; Haider MA; Fleshner N; Finelli A; Ghai S
J Urol; 2019 Dec; 202(6):1159-1165. PubMed ID: 31188731
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN
J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225
[TBL] [Abstract] [Full Text] [Related]
4. Do Sociodemographic Factors Influence outcome in prostate cancer Patients Treated With External Beam Radiation Therapy?
Movsas A; Ibrahim R; Elshaikh MA; Lamerato L; Lu M; Sitarik A; Pradhan D; Walker EM; Stricker H; Freytag SO; Chetty IJ; Movsas B; Siddiqui F
Am J Clin Oncol; 2016 Dec; 39(6):563-567. PubMed ID: 24879473
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens.
Ichihara K; Masumori N; Kitamura H; Hasegawa T; Tsukamoto T
Int J Clin Oncol; 2014 Feb; 19(1):152-6. PubMed ID: 23250619
[TBL] [Abstract] [Full Text] [Related]
6. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer.
Servoll E; Saeter T; Vlatkovic L; Lund T; Nesland J; Waaler G; Axcrona K; Beisland HO
BJU Int; 2012 May; 109(10):1489-94. PubMed ID: 21933333
[TBL] [Abstract] [Full Text] [Related]
7. outcomes after prostate brachytherapy are even better than predicted.
Frank SJ; Levy LB; van Vulpen M; Crook J; Sylvester J; Grimm P; Pugh TJ; Swanson DA
Cancer; 2012 Feb; 118(3):839-47. PubMed ID: 21751187
[TBL] [Abstract] [Full Text] [Related]
8. Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome.
Hinnen KA; Moerland MA; Battermann JJ; van Roermund JG; Monninkhof EM; Jürgenliemk-Schulz IM; van Vulpen M
Radiother Oncol; 2010 Jul; 96(1):30-3. PubMed ID: 20215039
[TBL] [Abstract] [Full Text] [Related]
9. Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature.
Saad F; Finelli A; Dranitsaris G; Goldenberg L; Bagnell S; Gleave M; Fleshner N;
Can J Urol; 2006 Jun; 13 Suppl 3():16-24. PubMed ID: 16818008
[TBL] [Abstract] [Full Text] [Related]
